TrialInfluenza and other respiratory viruses2013

Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6-35 months: a randomized, double-blind, controlled phase I clinical trial.

Yan-Ping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.